Fulminant Clostridioides difficile Infection: A Journey into the Unknown!

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Microbiology

Background:

• Clostridioides difficile is a major antibiotic resistance threat.
• Fulminant Clostridioides difficile infection (CDI) presents as critical illness with hypotension, shock, or megacolon.
• Defining and treating fulminant CDI remains challenging.

Purpose of the Study:

• To outline diagnostic criteria for fulminant CDI.
• To identify clinical factors and inflammatory markers associated with severe CDI.
• To review current and investigational treatment strategies for fulminant CDI.

Main Methods:

• Review of diagnostic criteria for fulminant CDI.
• Analysis of clinical factors and inflammatory markers.
• Compilation of recommended and investigational treatments.

Main Results:

• Diagnostic criteria for fulminant CDI are presented.
• Key clinical and inflammatory markers are discussed.
• Current treatments include antibiotics, colectomy, and ileostomy.
• Investigational treatments include microbiota transplant, tigecycline, and IVIG.

Conclusions:

• Accurate diagnosis of fulminant CDI is crucial.
• A combination of antibiotics and surgical interventions is often necessary.
• Investigational therapies show promise for refractory cases.